323 related articles for article (PubMed ID: 32861136)
1. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.
Chan B; Freeman M; Ayers C; Korthuis PT; Paynter R; Kondo K; Kansagara D
Drug Alcohol Depend; 2020 Nov; 216():108193. PubMed ID: 32861136
[TBL] [Abstract][Full Text] [Related]
2. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE
JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
[TBL] [Abstract][Full Text] [Related]
4. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
[TBL] [Abstract][Full Text] [Related]
5. Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis.
Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
J Clin Psychiatry; 2022 Jun; 83(4):. PubMed ID: 35759785
[No Abstract] [Full Text] [Related]
6. Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis.
Chan B; Kondo K; Freeman M; Ayers C; Montgomery J; Kansagara D
J Gen Intern Med; 2019 Dec; 34(12):2858-2873. PubMed ID: 31183685
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of psychostimulant drugs for cocaine dependence.
Castells X; Casas M; Pérez-Mañá C; Roncero C; Vidal X; Capellà D
Cochrane Database Syst Rev; 2010 Feb; (2):CD007380. PubMed ID: 20166094
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial interventions for stimulant use disorder.
Minozzi S; Saulle R; Amato L; Traccis F; Agabio R
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD011866. PubMed ID: 38357958
[TBL] [Abstract][Full Text] [Related]
9. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.
Frost MC; Lampert H; Tsui JI; Iles-Shih MD; Williams EC
Addict Sci Clin Pract; 2021 Oct; 16(1):62. PubMed ID: 34635170
[TBL] [Abstract][Full Text] [Related]
10. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.
Castells X; Casas M; Vidal X; Bosch R; Roncero C; Ramos-Quiroga JA; Capellà D
Addiction; 2007 Dec; 102(12):1871-87. PubMed ID: 18031423
[TBL] [Abstract][Full Text] [Related]
12. Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations.
Cook RR; Foot C; Arah OA; Humphreys K; Rudolph KE; Luo SX; Tsui JI; Levander XA; Korthuis PT
Addict Sci Clin Pract; 2023 Feb; 18(1):11. PubMed ID: 36788634
[TBL] [Abstract][Full Text] [Related]
13. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
Shearer RD; Jones A; Howell BA; Segel JE; Winkelman TNA
J Subst Abuse Treat; 2022 Dec; 143():108894. PubMed ID: 36206585
[TBL] [Abstract][Full Text] [Related]
14. Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
Chawarski MC; Hawk K; Edelman EJ; O'Connor P; Owens P; Martel S; Coupet E; Whiteside L; Tsui JI; Rothman R; Cowan E; Richardson L; Lyons MS; Fiellin DA; D'Onofrio G
Ann Emerg Med; 2020 Dec; 76(6):782-787. PubMed ID: 32782084
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.
Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M
Lancet Psychiatry; 2023 Jun; 10(6):386-402. PubMed ID: 37167985
[TBL] [Abstract][Full Text] [Related]
16. Psychostimulant drugs for cocaine dependence.
Castells X; Cunill R; Pérez-Mañá C; Vidal X; Capellà D
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD007380. PubMed ID: 27670244
[TBL] [Abstract][Full Text] [Related]
17. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Jordan CJ; Cao J; Newman AH; Xi ZX
Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
Blanken P; Nuijten M; van den Brink W; Hendriks VM
Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
[TBL] [Abstract][Full Text] [Related]
19. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
Saulle R; Vecchi S; Gowing L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
